Status:
UNKNOWN
Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo
Lead Sponsor:
Sohag University
Conditions:
Vitiligo
Tacrolimus
Eligibility:
All Genders
2+ years
Phase:
PHASE1
PHASE2
Brief Summary
The study will evaluate the effectiveness of Tacrolimus 0.03% ointment monotherapy in patients with vitiligo. Patients will be treated for 6 months and followed for 3 months after treatment. All types...
Detailed Description
Study approval: The study was submitted for approval by Scientific and Ethical Committee at Faculty of Medicine, Sohag University. An informed written consent will be obtained from all participants. ...
Eligibility Criteria
Inclusion
- all patients with clinical diagnosis of vitiligo
Exclusion
- children =or \<2 years old, women who are pregnant or lactating, patients with acute or chronic disease that might affect skin barrier function.
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03358082
Start Date
October 1 2017
End Date
February 1 2019
Last Update
November 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University
Sohag, Egypt